LETROZOLE DEXCEL

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Bahan aktif:

LETROZOLE

Boleh didapati daripada:

DEXCEL LTD, ISRAEL

Kod ATC:

L02BG04

Borang farmaseutikal:

FILM COATED TABLETS

Komposisi:

LETROZOLE 2.5 MG

Laluan pentadbiran:

PER OS

Jenis preskripsi:

Required

Dikeluarkan oleh:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Kumpulan terapeutik:

LETROZOLE

Kawasan terapeutik:

LETROZOLE

Tanda-tanda terapeutik:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Tarikh kebenaran:

2016-02-29